Off-label drug use in children should be rational

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 870-871

  Bonati, Maurizio ^a   Pandolfini, Chiara ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; FLUOXETINE; PAROXETINE;

CHILDHOOD DISEASE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; EDITORIAL; HEALTH CARE POLICY; OFF LABEL DRUG USE; PEDIATRICIAN; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; CHILD; DRUG APPROVAL; DRUG LABELING; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HUMANS; OFF-LABEL USE;

EID: 80051825171     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300293     Document Type: Editorial

References (18)

1. Conroy S. Unlicensed and off-label drug use: issues and recommendations. Paediatr Drugs 2002;4:353-359 (Pubitemid 34651924)
2. Seyberth H.W. [Problems of drug safety in children (author's transl)]. Monatsschr Kinderheilkd 1982;130:529-535
3. Pandolfini C., Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552-558 (Pubitemid 41225059)
4. Yoon E.Y., Dombkowski K.J., Rocchini A., et al. Off-label utilization of antihypertensive medications in children. Ambul Pediatr 2007;7:299-303. (Pubitemid 47099494)
5. Abernethy A.P., Raman G., Balk E.M., et al. Systematic review: reliability of compendia methods for off-label oncology indications. Ann Intern Med 2009;150:336-343
6. Bavdekar S.B., Sadawarte P.A., Gogtay N.J., et al. Off-label drug use in a Pediatric Intensive Care Unit. Indian J Pediatr 2009;76:1113-1118
7. Choonara I. Regulation of drugs for children in Europe. BMJ 2007;335:1221-1222
8. Abraham J., Bardelay D., Kopp C., et al. Education and debate: Making regulation responsive to commercial interests: streamlining drug industry watchdogs. BMJ 2002;325:1164-1169
9. Clavenna A., Rossi E., Berti A., et al.; ARNO Working Group. Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol 2003;59:565-569 (Pubitemid 37363569)
10. Clavenna A., Bonati M. Antidepressant prescriptions in paediatric outpatients in Europe. Paediatr Perinat Drug Ther 2007;8:103-108
11. Hetrick S.E., Merry S.N., McKenzie J., et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007;3:CD004851.
12. Doherty D.R., Pascuet E., Ni A., et al. Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies. Can J Anaesth 2010;57:1078-1088
13. Aagaard L., Hansen E.H. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions. Br J Clin Pharmacol 2011;71:751-757
14. Hogerzeil H.V., Hill S., Rago L. Boosting access to essential medicines for children. Lancet 2006;368:1419. (Pubitemid 44573465)
15. World Health Organization. WHO Model Formulary for Children 2010. Geneva: WHO.
16. Bonati M., Pandolfini C. Is it time for a European formulary of paediatric medicines? Arch Dis Child 2004;89:890-891 (Pubitemid 39165969)
17. Hill P. Off licence and off label prescribing in children: litigation fears for physicians. Arch Dis Child 2005;90(Suppl 1):i17-i18 (Pubitemid 40187997)
18. Gazarian M., Kelly M., McPhee J.R., et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust 2006;185:544-548 (Pubitemid 44816941)